Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription

Ming Heng Wu, Wen Lung Ma, Cheng Lung Hsu, Yuh Ling Chen, Jing Hsiung James Ou, Charlotte Kathryn Ryan, Yao Ching Hung, Shuyuan Yeh, Chawnshang Chang

研究成果: Article同行評審

138 引文 斯高帕斯(Scopus)

摘要

Hepatitis B virus (HBV)-induced hepatitis and carcinogen-induced hepatocellular carcinoma (HCC) are associated with serum androgen concentration. However, how androgen or the androgen receptor (AR) contributes to HBV-induced hepatocarcinogenesis remains unclear. We found that hepatic AR promotes HBV-induced hepatocarcinogenesis in HBV transgenic mice that lack AR only in the liver hepatocytes (HBV-L-AR-/y). HBV-L-AR-/y mice that received a low dose of the carcinogen N′-N′-diethylnitrosamine (DEN) have a lower incidence of HCC and present with smaller tumor sizes, fewer foci formations, and less α-fetoprotein HCC marker than do their wild-type HBV-AR+/y littermates. We found that hepatic AR increases the HBV viral titer by enhancing HBV RNA transcription through direct binding to the androgen response element near the viral core promoter. This activity forms a positive feedback mechanism with cooperation with its downstream target gene HBx protein to promote hepatocarcinogenesis. Administration of a chemical compound that selectively degrades AR, ASC-J9, was able to suppress HCC tumor size in DEN-HBV-AR+/y mice. These results demonstrate that targeting the AR, rather than the androgen, could be developed as a new therapy to battle HBV-induced HCC.

原文English
頁(從 - 到)32ra35
期刊Science translational medicine
2
發行號32
DOIs
出版狀態Published - 2010

All Science Journal Classification (ASJC) codes

  • 醫藥 (全部)

指紋

深入研究「Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription」主題。共同形成了獨特的指紋。

引用此